Skip to main content
. Author manuscript; available in PMC: 2013 Apr 11.
Published in final edited form as: Int Urol Nephrol. 2011 Jun 26;44(2):459–470. doi: 10.1007/s11255-011-0020-0

Table 7.

Restricted multivariable analysis for the prediction of pathologic upstaging in potential active surveillance patients

Predictors of upstaging P value Adjusted OR 95% C.I. for OR
Lower Upper
Preop PSA 0.060 1.212 0.992 1.481
Clinical stage 0.394 1.937 0.423 8.865
Positive cores 0.083 1.946 0.917 4.129
Prostate volume 0.046 0.976 0.953 1.000

PA = 65.2%; Preop PSA: Continuous in model; Clinical stage: t2 versus t1 (referent); Positive cores: 2 positive cores versus 1 positive core (referent); Prostate volume: Continuous in model